Magenta Therapeutics, Inc.·4

Sep 16, 4:37 PM ET

Olson Lisa 4

4 · Magenta Therapeutics, Inc. · Filed Sep 16, 2020

Insider Transaction Report

Form 4
Period: 2020-09-14
Olson Lisa
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-09-14+120,000120,000 total
    Exercise: $7.77Exp: 2030-09-13Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on September 14, 2021, with the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION